Patient Resources
Action Plans
This section contains the customizable action plans for patients with different tumor types that have been customized for the UK audience. We wish to thank Kris Griffin, patient advocate, for his helpful review of these materials.
Talimogene laherparepvec; T-VEC
Pembrolizumab
- Bladder (Urothelial) Cancer
- Gastric/GEJ Cancer
- Head and Neck Squamous Cell Carcinoma
- Hodgkin Lymphoma, Classical
- Lung Cancer, Non-Small Cell
- Melanoma
Nivolumab
- Bladder (Urothelial) Cancer
- Head and Neck Squamous Cell Carcinoma
- Hodgkin Lymphoma, Classical
- Kidney Cancer (Renal Cell Carcinoma)
- Lung Cancer, Non-Small Cell
- Melanoma